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The prevalence of diabetes mellitus (DM) continues to be a global concern among health 
care practitioners. Without collaboration and interventions, this chronic disease, which 
poses a significant financial burden for health care institutions, will continue to be 
problematic. Promoting the use of glycemic control measures among diabetic patients is 
an intervention, which has the potential to reduce diabetic complications and improve 
outcomes. The purpose of this doctoral project was to explore available evidence through 
a systematic review of the best practices for glucose management. The chronic care 
model served as the theoretical framework. The evidence based practice question was, 
What is the current evidence supporting the utilization of a computer-based glucose 
management system (CBGMS) for inpatient diabetic adults in acute and critical care 
settings? A systematic review was conducted, yielding 532 studies in which 3 of the 
studies related to CBGMSs published from 2008 to 2017 were critically appraised. The 
John Hopkins Nursing Evidence Appraisal Tool with specific inclusion and exclusion 
criteria was utilized. Participants were adult patients (aged 18 and over) with DM in 
inpatient care settings who were English speaking. Interventions included the traditional 
paper-based sliding scale regimen versus the utilization of a CBGMS. Outcome measures 
included decreased length of stay, reduced cost, and glucose optimization. A conclusion 
was the implementation of a CBGMS has the potential to improve patient outcomes with 
additional research that exhibits overall benefits and implement into practice. Thus, 
implementation of a CBGMS can lead to positive social change by aiding in a change in 
practice that will ultimately ameliorate patient health outcomes.  
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Section 1: Nature of the Project 
Introduction 
Diabetes mellitus (DM) type 1 and 2 are complex disease processes that have 
affected the United States in several key ways. In 2015, there were 30.3 million 
Americans, which is equivalent to 9.4% of the U.S. population, suffering from diabetes 
(American Diabetes Association, 2016c). There are approximately 1.25 million children 
and adults in America with type 1 diabetes (American Diabetes Association, 2016c). To 
date, there are reportedly 1.5 million new cases of Americans who have been diagnosed 
with diabetes yearly in the United States and the mortality rate for these individuals has 
risen significantly (American Diabetes Association, 2016c). Presently, diabetes remains 
the 7th leading cause of death in the United States, with 252,806 death certificates listing 
DM as the underlying reason for death in the U.S. population in 2015 (American 
Diabetes Association, 2016c).  
The estimated total cost for individuals diagnosed with DM type 1 and 2 in the 
United States rose to $245 billion in 2012 from $174 billion in 2007 (Romero, 2016). 
This chronic illness poses a substantial financial burden for the United States with the 
noted rise of the total cost from 2007 to 2012. The complications associated with DM 
also may lead to exorbitant health care costs and medical expenditures (American 
Diabetes Association, 2016a). Results of the Diabetes Control and Complications Trial 
(DCCT) showed that thorough glycemic control reduces microvascular and 
macrovascular complications in patients who suffer from DM type 1 and 2 (Gregg, Li, 
Wang, Burrows, Ali, Rolka, Williams, & Geiss, 2014). These complications include but 
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are not limited to retinopathy, nephropathy, neuropathy, ischemic heart disease, 
peripheral vascular disease, and cerebrovascular disease (Gregg et al., 2014).  
Thus, the use of a computer-based glucose management system (CBGMS) could 
aid health care professionals in ameliorating patient care by: optimizing patients’ glucose 
levels, reducing overall health care cost and medical expenditures, and decreasing 
complications manifested by poor glycemic control (Mann, Jones, Wolf & Wade, 2011). 
Additionally, the Centers for Medicare and Medicaid Services (CMS) have deemed the 
manifestations of inadequate glucose control as a preventable error which presents a 
financial burden to health care organizations (Romero, 2016). Consequently, there are 
also significant risks associated with inpatient hyperglycemic and hypoglycemic events 
including but not limited to increased mortality rates, longer length of stay (LOS), and an 
increased risk for intensive care unit (ICU) admission (Tanenberg, Hardee, Rothermel, & 
Drake, 2017). 
These risks have led to efforts by health care professionals to maintain optimal 
glucose control in the hospital setting. Tanenberg et al. (2017), indicated that 
approximately 8% of patients that are admitted into the hospital setting will experience at 
least 1 hyperglycemic or hypoglycemic event. The use of CBGMSs has also been found 
to have very successful outcomes within the inpatient care population (Tanenberg et al., 
2017). CBGMSs utilize algorithms and/or clinical decision support software, which 
provide therapy recommendations (Tanenberg, 2017).  
There is substantial evidence supporting the utilization of a CBGMS versus the 
traditional sliding scale protocol (Tanenberg, 2017). The traditional sliding scale protocol 
3 
 
entails rapid-acting insulin administration to aid in rising blood glucose levels pre-meal 
time and is adjusted based on the blood glucose level (Trotter, Conaway, & Burns, 2013). 
The results were quite significant in a study discussed in Tanenberg et al. (2017), in 
which patients who had undergone cardiac surgery with their blood glucose level 
controlled with the utilization of a CBGMS were compared to patients who had their 
glucose level controlled with utilization of the traditional sliding scale regimen. The 
study authors found that cardiac patients who had used the CBGMS had a 2.5-fold 
decrease related to post-operative complications (Tanenberg et al., 2017).  
The traditional sliding scale insulin regimen has been the standard of care and the 
most common strategy used to treat patients suffering from diabetes since the 1970s 
(Badlani, Ford, Yu, Brogan, Pollack, & Volturo, 2014). However, treating patients solely 
with this regimen has been found to be ineffective (Badlani et al., 2014). Thus, in 2006, 
the American College of Endocrinology (ACE) and the American Diabetes Association 
(ADA) recommended that insulin protocols, along with algorithms, and/or order sets be 
used to treat hyperglycemia and hypoglycemia events in the inpatient hospital care setting 
(Tanenberg et al., 2017). The aim of this DNP project was to conduct a systematic review 
of the literature on the use of CBGMSs for inpatient adults. 
Problem Statement 
Despite the progress and advancements of CBGMS, many organizations and 
health care providers are reluctant to consider these systems to aid in caring for their 
patients (Mann, et al., 2011). There are several reasons accounting for health care 
providers’ reluctance in adopting CBGMSs. Some of the reasons include (a) lack of Food 
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and Drug Administration (FDA) approval for insulin dosing in the United States; (b) cost 
and reimbursement issues; (c) the recalibration requirement for the systems; (d) training 
time and the cost for health care professionals who care for diabetic patients within an 
organization; (e) lack of standardization in available software; (f) the need for more 
clinical practice guidelines regarding the role of CBGMS; and (g) the need for the clinical 
research to be disseminated to all health care organizations and professionals to aid in 
determining best practice (Rodbard, 2016).  
The common practice of providers utilizing standard protocols and sliding scale 
glucose management alone has proven to be ineffectual over time (Mann, Allen, Serio-
Melvin, Wolf, & Salinas, 2012). Health care organizations and providers are being held 
to a higher standard when caring for diabetic patients. This higher standard of care is 
recommended and supported by the American Diabetes Association. The American 
Diabetes Association (2016) recommends that health care organizations and providers 
use a patient-centeredness approach when caring for diabetic patients. This means that 
health care organizations and providers must provide a comprehensive plan of care for 
diabetic patients to aid in addressing and reducing complications (American Diabetes 
Association, 2016). Health care organizations and providers must also have a sound care 
team (American Diabetes Association, 2016b). This care team includes but is not limited 
to the primary care provider, diabetic educator, registered dietician, endocrinologist, 
ophthalmologist, social worker, podiatrist, pharmacist, dentist, and family members or 
caregivers (American Diabetes Association, 2016b). Moreover, the American Diabetes 
Association recommends the utilization of decision support tools to aid in meeting 
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diabetic patient needs (American Diabetes Association, 2016). CBGMSs are considered a 
decision support tool.  
CBGMSs integrate software that utilizes point of care glucose levels to determine 
the appropriate insulin needed to achieve the desired glucose range (Mann et al., 2012). 
According to Mann et al. (2012), undesirable outcomes for diabetic patients could 
continue until health care organizations and providers are willing to enhance their 
knowledge base and contemplate adopting an assistive computer-based decision support 
system. Researching best practices related to glucose management and disseminating this 
research to health care professionals, could aid in the use of CBGMS for diabetics in the 
inpatient care setting. In developing this systematic review of evidence, I wanted to aid in 
closing the research-practice gap and provide the evidence necessary to support the 
adoption of CBGMSs for managing diabetics in the inpatient care setting. Adopting 
CBGMS could aid in improving patient outcomes, safety, and quality of care and 
reducing mortality (Crockett et al., 2012).   
Purpose 
Identifying evidence regarding the utilization of a CBGMS for the management of 
glucose levels for inpatient adults was the purpose for this systematic review. I used the 
Johns Hopkins Nursing Evidence-Based Practice Levels of Evidence tools for this 
systematic review (see Appendix D and E). The Johns Hopkins Nursing Evidence-Based 
Practice: Levels of Evidence systematic review is used to analyze RCTs (randomized 
controlled trials) and quasi-experimental studies with or without-meta analysis or 
synthesis (John Hopkins Medicine Center for Evidence Based Practice 2017). Non-
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experimental studies, opinions from respected authorities, literature reviews, and case 
reports are also analyzed (John Hopkins Medicine Center for Evidence Based Practice 
2017).  
The organization in which I completed my DNP practicum experience hours hired 
an inpatient diabetic coordinator (IDC) in early 2016. Since the hiring of the IDC, the 
organization has been seeking ways to improve the care provided to its adult inpatient 
diabetic population. The new IDC developed a diabetes management program (DMP) and 
created a diabetes steering committee (DSC). It was decided by myself to conduct 
research and perform a systematic review for the committee on the benefits of the 
utilization of a CBGMS. This was decided because the organization’s sister facility was 
utilizing a system called EndoTool which is a CBGMS. According to an official at the 
practicum site, EndoTool has improved the sister facility’s outcomes, and the 
organization could benefit from a systematic review on CBGMSs.  
 A systematic review was conducted and carried out prospectively and 
comprehensively. This review was structured utilizing the Johns Hopkins Nursing 
Evidence-Based Practice Project Management Guide (see Appendix B). There were a 
total of 18 steps that could be used to carry out a project utilizing the Johns Hopkins 
Nursing Evidence-Based Practice Project Management Guide. However, this project was 
a systematic review, for which the pertinent steps were 1 through 11, 16, 17, and 18 (see 
Appendix B). Step 12 was eliminated because it requires an action plan. This is a 
systematic review that will be presented to the IDC and the DSC, and an action plan is 
not required. Step 13 was eliminated because it requires support and resources to 
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implement the action plan and there is no action plan needed for this systematic review 
and the method of dissemination. Step 14 was eliminated because it requires the 
implementation of the action plan and this is not required for this systematic review. Step 
15 was eliminated because it requires evaluation of outcomes. This is a systematic review 
that will be presented to the IDC and DSC and the decision to adopt a CBGMS will 
solely rely on their decision.  
I drew from the Johns Hopkins Nursing Evidence-Based Practice Question 
Development Tool (see Appendix C) in developing the evidence-based practice question 
developed for this systematic review. The evidence based practice question for this 
systematic review was, What is the current evidence supporting the utilization of a 
CBGMS for inpatient diabetic adults in acute and critical care settings? 
Nature of the Doctoral Project 
In conducing this review, I explored the available evidence following a systematic 
format. A systematic review is defined as a “review of a clearly formulated question that 
uses systematic and explicit methods to identify, select, and critically appraise relevant 
research” (Ham-Baloyi & Jordan, 2016, p. 122). According to Gough, Oliver, and 
Thomas (2012), researchers performing systematic reviews use explicit, rigorous, and 
accountable methods to identify gaps in existing literature.  
This review was conducted by accessing databases such as CINAHL Plus with 
Full Text, MEDLINE with Full Text, and Cochrane Systematic Reviews. Search 
methodology, terms, and results are discussed in detail in Section 3. This systematic 
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review provides a summary of the available evidence to support further decision making 
in acute and critical care settings to help narrow the knowledge-practice gap. 
Significance 
Traditional sliding-scale insulin has widely been utilized and deemed the 
treatment of choice for an extended timeframe for health care professionals in their daily 
practice (Guthrie, Hinnen, & Childs, 2011). Despite the wide acceptance of the utilization 
of traditional sliding-scale insulin and glycemic control for those experiencing 
hypoglycemia or hyperglycemia, there is little evidence supporting its efficacy (Guthrie 
et al., 2011). There are potential complications associated with using the traditional 
sliding scale regimen for glycemic control for episodes of hypoglycemia and 
hyperglycemia (Guthrie et al., 2011). Traditional sliding scale insulin has also been 
linked to an increased fluctuation of blood glucose levels (Guthrie et al., 2011). 
Moreover, the fluctuation of blood glucose levels is viewed as unfavorable to patients 
physiologically (Guthrie et al., 2011).  
The American Diabetes Association (ADA) also plays an integral role in diabetes 
care and management in the United States. It is the ADA’s recommendation to increase 
the quantity of individualized care provided in the treatment of those with DM (American 
Diabetes Association, 2013). The individualized care includes an individualized care plan 
and a road map that will outline goals specific to the patient needs. This recommendation 
has been revised and published in the January 2014 issue of Diabetes Care for Standards 
of Medical Care (American Diabetes Association, 2013). Moreover, this recommendation 
encourages health care professionals to examine an array of options and not solely the 
9 
 
traditional methods of treatment. In conducting this review, I sought to appraise the 
current body of evidence to discern if there is enough evidence available to prospectively 
work towards translating the concept of utilization of CBGMS into practice. The 
identified stakeholders for this review were providers and affected patients with DM type 
1 or 2.     
Summary 
 The purpose of Section 1 was to provide background information based on the 
systematic review. This included the review question, purpose of the study, and nature of 
the study. The introduction in this section provided the background information into the 
project and the thought process on why it is vital to practice appropriate glucose 
management for inpatient adults in acute and critical care settings. The utilization of a 
CBGMS in the electronic health record (EHR) has been found to ameliorate diabetics’ 
outcomes during hospitalization (Tanenberg et al., 2017). A change in the way that health 
care organizations provide treatment to patients with DM can advance the organizations 
knowledge and optimize the quality of care delivered. Properly managing patients’ 
glucose level is deficient in many health care organizations in the United States (Romero, 
2016). If DM is not managed appropriately, it may lead to an increase in inpatient 
population admissions, re-admissions, mortality rates, morbidity rates, diabetic 






Section 2: Background and Context 
Introduction 
Computer decision glucose management support systems ameliorate patient care 
by comparing distinctive characteristics with a sound knowledge base providing 
customized clinical recommendations (Gillaizeau et al., 2013). According to Gillaizeau et 
al. (2013), “ideally, decision support, integrated in the electronic medical record as the 
platform, can provide physicians with tools making it possible to improve practice and 
patient safety” (p. 8). An effective computer decision support glucose management 
system can aid health care professionals in predicting patients’ specific needs and 
promptly conveying information (Gillaizeau et al., 2013). CBGMSs can aid health care 
professionals in ameliorating patient outcomes more frequently than the traditional paper-
based insulin titration regimen it substitutes, while accomplishing significantly fewer 
hypoglycemic episodes (Mann et al., 2012).  
Concepts, Models, and Theories 
Glucose management is an integral component of nursing care. Preventing 
adverse outcomes and treating glucose levels in inpatient adults should take precedence 
when caring for diabetic patients (American Diabetes Association, 2016b). The chronic 
care model (CCM) served as the theoretical framework for my systematic review the use 
of a CBGMS with inpatient adults in acute and chronic care settings. The CCM employs 
a systematic approach with a combination of components (Stellefson, Dipnarine, & 
Stopka, 2013). According to Stellefson et al. (2013), this model utilizes “decision-support 
components to train providers on guidelines for American Diabetes Association (ADA) 
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Standards of Care” (p. 21). This model also utilizes a system design component to aid in 
remodeling the care delivery process to provide self-management support through 
diabetes self-management education (DSME) (Stellefson et al., 2013). The combination 
of components utilized to promote optimized quality chronic disease care includes the 
community, the health system, self-management delivery system design, decision support 
and clinical information systems (The Chronic Care Model, 2017). Each component has 
evidence-based change concepts linked to it. Together, the components and elements of 
the CCM foster valuable interactions between the patient and the health care professional 
(The Chronic Care Model, 2017). These elements include patient safety (the health 
system), cultural competency (the self-management delivery system design), care 
coordination (the health system and clinical information systems), community policies 
(the community resources and policy), and case management (in the self-management 
delivery system design; The Chronic Care Model, 2017).  
There is evidence showing that use of the CCM effectively improves the health of 
diabetic patients, with positive outcomes well documented in several studies (Stellefson 
et al., 2013; see Figure I1). Similarly, the American Diabetes Association (2016) 
recommends that care be aligned with the components of the CCM. The Association 
made the recommendation to “ensure productive interactions between a prepared, 
proactive practice team and an informed, activated patient” (American Diabetes 
Association, 2016, p. 1). The CCM model also aids health care professionals in 
facilitating patients’ self-management by supporting patient behavior change and 
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providing a coordinated care team to aid in optimal diabetes management (American 
Diabetes Association, 2016).  
The evidence-based practice question I sought to answer concerned whether there 
is a sufficient quantity of evidence to support the utilization of a CBGMS, on the basis 
that this type of system can prospectively yield positive results and improve glucose 
levels with inpatient adults. Diabetes can cause many adverse outcomes including 
increased length of stay in the hospital and microvascular and macrovascular 
complications (Romero, 2016). For these reasons, it is important that health care 
professionals seek out systems or processes that can bestow positive outcomes for 
patients and health care organizations.  
Relevance to Nursing Practice 
Health care professionals around the United States strain to stabilize managing 
DM due to the many existing challenges and barriers in the practice setting (Crockett et 
al., 2012). It is estimated that DM affects 24 million Americans a year, which makes this 
illness one of the most chronic diseases in the United States (Miller & Dimatteo, 2013). 
The number of DM diagnoses is expected to double by 2034 (Miller & Dimatteo, 2013). 
Diabetes has been linked to “heart disease, stroke, kidney failure, lower limb amputation, 
and blindness” (Miller & Dimatteo, 2013, p. 422).  
Diabetic patients must adhere to strict treatment such as medication including 
insulin injections, self-monitoring of blood glucose levels, strict dietary changes, frequent 
vision examinations, and daily exercise routines (Miller & Dimatteo, 2013). The strict 
treatment regimen that patients suffering from DM follow, makes it imperative for nurses 
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to provide adequate glucose management for all inpatient diabetic patients in the acute 
and critical care setting. For a number of years, health care organizations around the 
United States have provided the standard traditional sliding scale insulin regimen (Mann 
et al., 2012) to patients with DM. There is evidence supporting the expansion of the 
traditional practice of glucose management in acute and critical care settings (Mann et al., 
2012). However, according to my review of the literature, little has been done to translate 
the evidence into practice.  
The U.S. public’s opinion is assessed by the Gallup poll annually. The Gallup poll 
measures issues that matter to the society which includes but not limited personal safety, 
well-being, and confidence in national institutions such as health care organization 
(Gallup, 2017). For 13 plus years, the results of the Gallup poll have shown that 
Americans rate nursing “as the most honest profession and nurses as having the highest 
ethical standards” (Winland-Brown, Lachman, & Swanson, 2015, p.268). The American 
Nurses Association’s (ANA) Code of Ethics is comprised of nine provisions (Winland-
Brown et al., 2015). The first three provisions explain the most essential merits, values, 
and commitments for a practicing nurse (Winland-Brown et al., 2015). Also, the first 
three provisions address nursing duties, how patients should be respected, and the need 
for consideration of social and economic status, personal attributes, and the nature of 
health problems (Windland-Brown et al., 2015). The fourth provision addresses how a 
nurse should be held accountable in day-to-day practice (Winland-Brown et al., 2015).  
Provisions 5 and 6 of the ANA Code of Ethics primarily focus on do’s and don’ts 
of nursing duties and issues of loyalty (Lachman, Swanson, & Windland-Brown, 2015). 
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Similarly, Provisions 7 through 9 focus on nurses’ ethical duties. However, these 
provisions support the notion that nurses are obligated to be directly involved in health 
policy as well as responsible to contributing nursing knowledge through scholarly inquiry 
and research (Lachman et al., 2015). With all of this noted, it is a nurse’s sworn duty to 
ensure that all patients are cared for optimally and in a safe manner, and to stay current 
on evidence regarding best practices (Lachman et al., 2015). By providing an alternative 
way to manage glucose levels for inpatients, nurses can promote and advocate for the 
rights and overall health of their patients and provide safe care. Hence, the utilization of a 
CBGMS to care for inpatient diabetic patients is pertinent to nursing practice in acute and 
critical care settings.  
Local Background and Context 
The practicum site of this DNP student is a full service acute-care facility in the 
local area. The facility has over 1,600 employees and over 1,000 physicians employed, 
with over 70 specialties and subspecialties (Medical City Plano, 2017).  Overall the 
facility has a capacity of 493 beds and are in the process of building another inpatient 
unit. The review question was identified by myself during patient rounding on the 
Neuroscience Progressive Care Unit (NSPCU) and with the Inpatient Diabetes 
Coordinator (IDC). I have a nursing background with experience in caring for adults with 
diabetes mellitus. During my research on diabetes management, I discovered several 
different computerized clinical decision support systems for treatment of hyperglycemic 
and hypoglycemic episodes. I am an active member of the diabetes steering committee 
(DSC) within the practicum site. When asked about the possible utilization of a CBGMS, 
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the diabetes steering committee members noted that they have heard of a CBGMS called 
EndoTool. They stated that one of their sister facility utilizes it. The committee members 
stated that to their knowledge, there is not enough sufficient evidence to support the 
utilization of a CBGMS (S. Harris, personal communication, September 15, 2016). 
Moreover, the members also stated that the cost associated with the software that is 
needed to be integrated into the EHR was too expensive to even consider. This prompted 
the need for further investigation on my part and the formulation of the review question 
to present to the diabetes steering committee (DSC).  
Role of the DNP Student 
The essential skills of a DNP prepared nurse bestow collaboration and utilization 
of leadership skills to “improve patient outcomes, the creation of new collaborative care 
delivery models that will meet the increasing demand for services, and the development 
of policy to enhance services and remove practice barriers” (Houghton, Casal, Fortuna, & 
Larsen, 2015, p.13).  As a Doctor of Nursing Practice (DNP) prepared student, my role in 
this project is to integrate knowledge acquired through my studies and exhibit 
representation of clinical evidence of CBGMSs to optimize clinical outcomes. This also 
entailed conducting a systematic review of literature on the review question. 
Summary 
Section 2 provided background and context information on CBGMSs and how the 
utilization of these systems can ameliorate patient care and patient outcomes. The clinical 
recommendations by the American Diabetes Association were also discussed in this 
section which aids in validating the feasibility and probability of the utilization of 
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CBGMSs. The CCM was identified as the appropriate theoretical framework for the DNP 
project in this section. The key components and elements that are encompassed within the 
CCM aid in optimizing patient outcomes not only in the inpatient care setting but also 
aids in self-management and behavior changes. The relevance to nursing practice, the 
local background and context of the practicum site, which noted the number of 
employees, specialists, sub-specialists, and bed capacity, provided details as to why and 
how adopting a CBGMS is relevant to current nursing practice. Lastly, the role of the 
DNP student was discussed in detail with emphasis on applying knowledge obtained 
through studies, collaborating with the DSC and IDC, and conducting a systematic 
review to support the adoption of a CBGMS for the practicum site.  
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Section 3: Collection and Analysis of Evidence 
Executive Summary 
Background 
Diabetes is the seventh leading cause of death in the United States (American 
Diabetes Association, 2016). Total costs of diagnosed diabetes are $245 billion annually, 
$176 billion for direct medical costs, and $69 billion in reduced productivity (American 
Diabetes Association, 2016). Without collaboration and interventions by health care 
professionals, the cost and numbers will continue to increase. Researchers have found 
that patients with DM type 1 and 2 who receive assistance from health care professionals 
with glycemic control measures show reduced microvascular and macrovascular 
complications (American Diabetes Association, 2016b). Despite the evidence exhibiting 
the advantages of tighter glycemic control within the inpatient adult population group 
there have been minimal efforts to translate the evidence into practice (Tanenberg et al. 
2017). 
This systematic review explored the evidence available on adult patients (those 
aged 18 and older) with type 1 or type 2 diabetes who are managed with the traditional 
sliding scale insulin protocol versus a CBGMS in acute and critical care settings. A future 
review would be beneficial to study the efficacy of a clinical decision support tool with a 
narrower age range. Glucose fluctuations have been found to contribute to adverse 
outcomes for patients in the inpatient population (Blair, Zamora, Brumbelow, & Mercer, 
2012). These fluctuations increase the mortality, morbidity, and length of stay in the 
hospital (Blair et al., 2012). Use of a computerized clinical decision support tool which 
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incorporates a software that is integrated into the EHR could aid in improving patient 
outcomes, reducing the financial burden faced by health care organizations, and 
decreasing patients’ LOS (Blair et al., 2012). 
The chronic care model (CCM) served as the theoretical framework for my 
project study of use of computerized clinical decision support systems for inpatient 
diabetic adults in acute and critical care settings (The Chronic Care Model, 2017). This 
model is comprised of decision support components that are used by health care 
professionals in providing optimal care for those suffering from a chronic illness such as 
DM (The Chronic Care Model, 2017). A literature review was performed with specific 
inclusion and exclusion criteria. The articles were appraised using the John Hopkins 
Nursing Evidence-Based Practice Research Evidence Appraisal Tool as a guide for 
qualitative studies (John Hopkins Medicine Center for Evidence Based Practice, 2017). 
Each article was categorized by level of evidence and quality rating. Results of my 
project analysis aided in supporting the utilization of a computerized clinical decision 
support tool and provided evidence of the need for future studies to narrow the gap in 
knowledge and practice. I received confirmation from the Walden’s University 
Institutional Review Board (IRB) to collect and analyze data from public reports and 
published literature on July 7, 2017. The IRB approval number is 07-07-17-0496733.  
Objectives 
The evidence based practice question was, What is the current evidence 
supporting the utilization of a CBGMS for inpatient diabetic adults in the acute and 
critical care settings? 
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Inclusion Criteria and Exclusion Criteria 
Type of participants. This review included studies of adult patients, who were 
aged 18 and over and who spoke the English language, and were in the inpatient setting 
with type 1 or type 2 DM, where they were using the traditional paper-based sliding scale 
method versus a CBGMS. Articles excluded were studies done on infants, children 4 
years of age or older, toddlers 12 to 36 months old, neonates under 28 days old, or adults 
less than 18 years of age, and any article written in a language other than English. The 
search was limited by years. A majority of the research was conducted over the past 7 
years, with the landmark study occurring 9 years ago in 2008. All duplicates have been 
removed.  
Type of intervention. This review included studies in which the traditional 
paper-based sliding scale glucose management regimen was compared to the utilization 
of a CBGMS.  
Types of outcomes.  
This review included studies examining the following outcome measures: 
decreased length of stay, reduced cost, optimized hyperglycemic, and hypoglycemic 
episodes.  
Types of studies.  
This review included systematic reviews from multiple other studies with meta-
analysis of RCTs, which studied inpatient adults treated with the traditional paper-based 
glucose regimen compared to a CBGMS. Cohort studies (prospective observational 
studies), systematic reviews without meta- analysis or synthesis, and quasi-experimental 
20 
 
studies were considered only in the absence of systematic reviews with meta-analysis or 
synthesis.  
Search Strategy 
The search strategy included both published and unpublished studies. A three-step 
search strategy was used in this review. An initial limited search of CINAHL, 
MEDLINE, and Cochrane was utilized followed by an analysis of the keywords 
contained in the title, abstract, and the index terms used to describe the article. A second 
search utilized all identified keywords and indexed terms to assess all included databases. 
Thirdly, the reference list of all relevant articles was searched for additional studies. 
Studies published or translated into English were considered for inclusion in this review. 
To remain consistent with the current technology of CBGMS, studies published between 
2008 and 2017 were considered for inclusion in this review. The databases included in 
the search were the following: 
• CINAHL Plus with Full Text, 
• MEDLINE with Full Text, 
• Cochrane Database of Systematic Reviews, 
• Ovid Nursing Journals Full Text, 
• PubMed, 
• Health Technology Assessments, 
• ProQuest Central, 
• Joanna Briggs Institute (JBI) Database of Evidence Based Practice, 




• Thoreau Multi-Database Search, and 
• Academic Search Complete. 
I also made an effort to identify literature that may not have been published. I searched 
for unpublished studies on the search engine Google Scholar and on the websites of the 
following organizations: American Diabetes Association, American Association of 
Clinical Endocrinologists, American College of Endocrinology, and International 
Diabetes Federation. 
Initial keywords included the following: type 1 diabetes, type 2 diabetes, adults, 
computer-based glucose management systems, computer glucose management systems, 
glucose management, acute care setting, critical care setting, traditional insulin sliding 
scale AND disadvantages, computer based AND glucose management, computer based 
glucose management system AND critical care, computerized glucose management 
systems, computer based glucose management AND acute care, and computer based 
glucose management algorithms. A detailed individual evidence summary tool/table was 
maintained. Please see Appendix F for a visual representation. 
Methodological quality. Papers selected for retrieval were assessed by one 
independent reviewer for methodological validity utilizing a standardized critical 
appraisal instrument from the Johns Hopkins Nursing Evidence-Based Practice Research 
Appraisal Tool. The independent reviewer possesses a Master’s of Science degree in 
nursing, with a specialty in Healthcare Systems Management. Likewise, the reviewer has 
also completed all course work for the Doctor of Nursing Practice terminal degree. The 
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Johns Hopkins Evidence Level and Quality Guide were utilized as a guide to aid in the 
grading level and quality of all papers received (Appendix D).  
Method of the Review 
After completing the search for studies and the study selection process, there were 
an abundance of studies collected but none that met the specific inclusion criteria for the 
review, which was determined to be too narrow. To aid in capturing more relevant data to 
answer the evidence based question, there was a decision made to deviate from the 
original protocol. Initially, the protocol intended to evaluate keywords: type 1 diabetes, 
type 2 diabetes, adults, computer-based glucose management systems, computer glucose 
management systems, glucose management, acute care setting, critical care setting, 
traditional insulin sliding scale AND disadvantages, computer based AND glucose 
management, computer based glucose management system AND critical care, computer 
based glucose management AND acute care, and computer based glucose management 
algorithms. However, the inclusion criteria was amended to include clinical decision 
support glucose management systems in order to capture all relevant data. 
Critical Appraisal 
The studies selected for retrieval were assessed by one independent reviewer for 
methodological validity prior to inclusion in the review utilizing a standardized critical 
appraisal instrument from the Johns Hopkins Nursing Evidence-Based Practice Research 
Evidence Appraisal Tool (Appendix E). The independent reviewer possesses a Master’s 
of Science degree in nursing, with a specialty in Healthcare Systems Management. 
Likewise, the reviewer has also completed all course work for the Doctor of Nursing 
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Practice terminal degree. With only one reviewer, gaining a consensus regarding the 
research assessment was not available and thus risked bias. Studies included required 
positive responses to questions number 1 through 15 of the Johns Hopkins Quality 
Appraisal of Research Studies and questions 1 through 12 of the Johns Hopkins Quality 
Appraisal of Systematic Review with or without Meta-Analysis or Meta-Synthesis 
(Appendix E).  
Data Extraction 
Data was extracted from studies included in the review utilizing the standardized 
data extraction tool from Johns Hopkins Nursing Evidence-Based Practice Appraisal 
Tool (Appendix E). The data extracted encompassed explicit details about the 
interventions, populations, study methods and outcomes of significance to the evidence 
based practice question and the specific objectives.  
Data Synthesis 
Data synthesis was assisted by the utilization of the Johns Hopkins Nursing 
Evidence-Based Practice Synthesis of Evidence Guide and Recommendation Tool 
(Figure I2).  
Results 
The initial literature search results included approximately 532 studies of which 
each title was reviewed. From those titles, 177 articles were determined to be potentially 
relevant studies. Upon review of the abstracts, 158 articles were excluded from the 
review. Exclusion was due to age of the participants, pediatrics, different disease 
processes, telemedicine, smartphone decision support, different outcome measures 
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including study focus on hemoglobin A1c levels, diet, exercise, self-management, non-
systematic review randomized control trials (RCTs), or non-qualitative outcomes 
measures. The remaining 19 articles were reviewed in their entirety. All were excluded 
because they did not meet the inclusion criteria of: adult patients, speaking the English 
language, aged 18 and over, in the inpatient setting with type 1 or type 2 diabetes mellitus 
utilizing the traditional paper-based sliding scale method versus a computer-based 
glucose management system. The primary outcomes of the studies were different, or the 
study was not a systematic review randomized control trial with meta-analysis. Following 
the decision to amend the inclusion criteria to include clinical decision support glucose 
management systems a second review was conducted. After the second review of the full 
papers, a total of 16 papers were excluded. (Appendix G). This resulted in three papers, 
which met the inclusion criteria and were critically appraised by the reviewer. (Figure 
I3).  
Conclusions 
From the findings in the review, the implementation of a computer-based glucose 
management system versus the traditional paper-based sliding scale regimen has the 
potential to improve patient outcomes but more research studies are needed to validate its 
overall benefits.  
Implication for Practice 
The systematic review supported the initiative to, at the minimum, consider 
adopting a computer-based glucose management system in the inpatient care setting. 
Since the practicum site has not implemented any type of computer-based glucose 
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management system, a systematic review was conducted to address that need. During the 
systematic review, it was discovered that a sister facility of the organization had already 
adopted a computer-based glucose management system called EndoTool and the software 
was already integrated into their EHR system. The success of the systematic review in 
providing knowledge on best practices when caring for inpatient diabetes should increase 
the capability for healthcare professionals to optimize inpatient diabetic outcomes. The 
systematic review will be presented to the Diabetes Steering Committee (DSC) and the 
Inpatient Diabetic Coordinator (IDC), if approved for implementation the system can be 
adopted and mirror the practicum sites sister facility.  
Implication for Research 
There are several significant implications for future research. Ongoing research 
regarding the safety, efficacy, and effectiveness of computer-based glucose management 
systems should be at the forefront. Education that aids the practicum site in (a) training; 
(b) obtaining the skill-set to care for patients through the assistance of a computerized 
management system; and (c) education on maintenance of the system should also be 
ongoing if the decision is to adopt the system. There should be an ongoing assessment of 
the healthcare professionals (a) knowledge; (b) skillset; and (c) confidence in caring for 
the inpatient diabetic patients.  
Completion of the systematic review does suggest that there are benefits to 
computer-based management systems in general. Some of the benefits are (a) a 
therapeutic range could be reached and maintained; (b) it spearheads to an optimized 
physiological parameter more frequently; (c) it aids in ameliorating stabilization of 
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medications quicker; and (d) it is predicted to ultimately reduces the length of stay (LOS) 
and is cost-effective (Gillaizeau et al., 2013). However, with this information presented, 
it is imperative to continue research to validate the validity and feasibility of a computer-
based glucose management system.  
Keywords  
Type 1 diabetes, type 2 diabetes, adults, computer-based glucose management 
systems, computer glucose management systems, glucose management, acute care 
setting, critical care setting, traditional insulin sliding scale AND disadvantages, 
computer based AND glucose management, computer based glucose management system 
AND critical care, computer based glucose management AND acute care, computer 





Section 4: Findings and Recommendations 
Findings and Implications 
The Johns Hopkins Nursing Evidence-Based Practice Research Appraisal Tool 
(see Appendix E) and the Johns Hopkins Nursing Evidence-Based Practice Evidence 
Level and Quality Guide (see Appendix D) were used to evaluate and appraise the 
strength of the data extracted from all three research articles. All scientific data extracted 
went through a rigorous process, wherein I first appraised the level of evidence which is 
the study design, the quality of research studies, and the quality of systematic review with 
or without meta-analysis or meta synthesis and, then, surmised the quality rating based 
upon the quality appraisal. All three studies were systematic reviews of multiple other 
studies with meta-analysis of randomized controlled trials.  
The three studies included 30 plus RCTs. Data were extracted from several 
different scientific databases including Cochrane Central Register of Controlled Trials 
(CENTRAL), MEDLINE, PubMed, Ovid, EMBASE, Psych INFO, Web of Science, 
ASLIB Index to Theses, ProQuest Digital Dissertations and Theses, and CINAHL. All 
studies were full-text articles. All subjects were diagnosed with type 1 or type 2 DM and 
were over the age of 18. Fillmore, Bray, & Kawamoto (2013) was updated for a strategy 
search adapted from previous systematic reviews in 2013. Gillaizeau, et al. (2013) was 
updated earlier by the Cochrane systematic reviews which were first published in 2001 
and updated in 2008. Nieuwlaat et al. (2011) was updated with new studies in January 
2010 from MEDLINE, EMBASE, Evidence-Based Medicine Reviews, and Inspec 
databases. In all three studies, the participants were health care professionals who were 
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responsible for patient care. Data were extracted from RCTs, nonrandomized controlled 
trials (NRCTs), controlled before-after studies (CBA), and interrupted-time series (ITs). 
However, for this systematic review, I decided to focus on RCTs with meta-analysis were 
analyzed. There were two reviewers for each systematic review. For each study, a 
flowchart was used to show how articles were managed during the analysis.  
The researcher in all three studies identified what was known and/or not known 
and whether further research is needed to address any knowledge gaps. The purpose of 
each study was clearly presented. All literature reviewed was current with most sources 
within a 5-year timeframe from date of publication. With all control groups, the 
characteristics and demographics were similar and the interventions were the same to 
validate the feasibility of a CBGMS versus the traditional paper protocol. The researchers 
of all studies used reliable instruments to validate the research question or hypotheses. 
All results were presented clearly for the reviewer to interpret. The tables, diagrams, and 
figures included in all three studies entailed a narrative to explain content. In all three 
studies, limitations and how these limitations could be addressed were discussed. The 
reviewer also identified other limitations (see Appendix F). All three studies presented 
conclusions based off the results from their findings. The background information 
presented in all three studies discussed the purpose for the systematic review. All three 
studies included keywords or key terms and inclusion criteria that also matched the 
reviewer inclusive inclusion criteria list. All pertinent details were included in each study; 
these included design, sample size, methods utilized to extract data, results, strengths of 
the data extracted, limitations of the data extracted, and recommendations. To some 
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degree, the authors of each study appraised the evidence by stating whether the evidence 
was of high, good, or low quality.  
Assessment of Methodological Quality 
The three studies selected for assessment of methodological quality were 
evaluated by one independent reviewer for methodological validity prior to inclusion in 
the review using a standardized critical appraisal methodology, the Johns Hopkins 
Nursing Evidence-Based Practice Research Evidence Appraisal Tool (see Appendix E). 
Based on an independent review prior to the appraisal process,  
I decided a positive response was required to Items 1 through 15 of the Johns 
Hopkins Quality Appraisal of Research Studies and Questions 1 through 12 of the Johns 
Hopkins Quality Analysis of Systematic Review with or without meta-analysis or meta-
synthesis. However, following detailed review, all relevant assessment questions were 
addressed. Based on methodological quality assessment, three studies were included in 
the review (see Table 1).  
Table 1 
Number of Studies Included and Excluded in the Project Study 
Number of studies included  Number of studies excluded  
3 16 
 
Detailed Discussion of Findings 
Fillmore et al. (2013). Fillmore et al. (2013) is an evidence level I, quality level 
B RCT with meta-analysis. The authors described increasing health care costs, how 
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inpatient hospitalizations are the driving force for this increase, and how clinical decision 
support systems could aid in improving these issues (Fillmore et al., 2013). The findings 
in this systematic review exhibited that clinical decision support (CDS) systems are an 
optimizing approach to ameliorating care and reducing cost in inpatient care settings. The 
purpose of the Fillmore et al. (2013) systematic review was to analyze trials using CDS 
systems interventions that had the possibility of reducing inpatient care costs.  
Fillmore et al. (2013) searched and retrieved 7,663 articles and 78 manuscripts, 
78.2% of which were controlled before-after studies, and 15.4% of which were RCTs. 
Most of the manuscripts were published during the years 2008 and thereafter. Moreover, 
7,500 references were excluded after screening of titles and abstracts. A total of 163 full-
text articles were deemed potentials per Fillmore et al (2013), of which 78 met the criteria 
for inclusion for the review. A total of 70.5% of the studies exhibited clinical 
amelioration through financial and proxy financial measures (Fillmore et al., 2013). 
However, the actual financial impact was not measured adequately, and the researchers 
encouraged further research.  
The search strategy to retrieve articles included only MEDLINE through July 18, 
2013 (Fillmore et al., 2013). The following search terms were included: decision support 
systems, clinical; decision-making, computer-assisted; computerized decision support; 
reminder systems; guideline adherence; and medical informatics (Fillmore et al., 2013). 
The inclusion, exclusion, and objective criteria included clinical decision support systems 
in an inpatient setting, cost reduction, and decrease in length of stay. Exclusion criteria 
that specifically matched the reviewers’ exclusion criteria were non-English studies. The 
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study selection was similar to the reviewers with the titles and abstracts being evaluated 
by a single reviewer which aided in determining inclusion eligibility. All studies where 
data were extracted was full text. The trials that were extracted entailed outcomes that 
presented potential cost saving if a clinical decision support system was adopted. The 
Fisher’s exact test of independence was used to aid in the proxy cost measure. This test 
was used due to the two variables, cost and study setting. Fillmore et al (2013), Authors 
determined that a p-value of < 0.05 was significant. The proxy cost measures included 
length of stay, re-admissions rates, resource utilization metrics such as imaging studies, 
adverse events that may occur, and different process measures (Fillmore et al., 2013). 
Fifty-five (70.5%) of the studies reported a statistically and clinically significant 
improvement in a cost or proxy measure (Fillmore et al., 2013).  
It was concluded by Fillmore et al (2013), that CDS systems do represent a 
favorable approach to decrease inpatient care cost. This study did determine that there 
were benefits to adopting a CDS system to aid in reduction of inpatient care costs versus 
the traditional paper sliding scale insulin protocol. The researchers also mentioned that 
there is more research encouraged to support CDS and inpatient care cost. There is also a 
significant gap in research studies to show how CDS can reduce inpatient care cost 
indefinitely.  
Gillaizeau et al. (2013). Gillaizeau et al. (2013), evidence level I quality level A 
randomized control trial with meta-analysis paper described how physicians and other 
healthcare professionals frequently prescribe medications that only work during certain 
times and not consistently working always. This paper was a systematic review on how 
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these drugs are prescribed, the efficacy of the therapeutic index (TI), how it causes a 
therapeutic effect, and for how long the therapeutic effect lasts. This paper made a critical 
point in expressing how calculating and prescribing of medication can be very 
cumbersome for healthcare professionals in general. The paper went on to express how 
ascertaining the correct dosage is critical to the patients’ overall outcomes. The following 
databases were included to retrieve articles for the systematic review: EPOC Group 
Specialized Register, Reference Manager; Cochrane Central Register of Controlled Trials 
(CENTRAL), MEDLINE, Ovid; EMBASE, Ovid; and CINAHL, and EbscoHost 
(Gillaizeau et al., 2013). Another search was conducted from January 2012 to January 
2013 and were placed on the Studies Awaiting Classification. The reviewers of this 
review also searched the reference lists from other relevant studies from the studies they 
chose to analyze. This systematic review utilized a reference manger called reference 
manger 5 to aid in removing all duplicates. The authors reviewed the titles and abstracts 
first then excluded studies that were not pertinent. All studies included were full text 
studies which were screened by the reviewers. All extracted data was reviewed by the 
reviewers independently. They could come to a consensus by having a group discussion 
with four other review authors (Gillaizeau et al., 2013).  
The authors reviewed previous data abstraction and developed a checklist that 
aided in extracting decision support technical features such as: was the computerized 
advice given in real time or delayed or was dose recommendation given (Gillaizeau et al., 
2013). Bias was assessed in this review. This was guided by EPOC Risk for Bias 
checklist (Appendix H). Two authors examined the quality of evidence for each outcome 
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for the review ranking: high, moderate, low, or very low. A risk ratio was also utilized. 
This ratio was utilized to determine the probability of a hypoglycemic or hyperglycemic 
occurring. A standardized mean difference (SMD) with a 95% confidence interval (CI) 
was also utilized. The SMD measures the impact of the adverse event (diabetes crisis). 
The outcomes that were measured include: “proportion of participants or time for which 
the plasma drug concentrations was within the therapeutic range, proportion of 
participants or time for which the studied physiological parameter was maintained within 
the target range, time to achieve therapeutic control, proportion of participants with toxic 
drug levels, proportion of participants with clinical improvement, proportion of 
participants with adverse effects of drug therapy, proportion of deaths, length of hospital 
stay, and  total cost per participant” (Gillaizeau et al., 2013, p.9).   
There were 42 trials with 40 randomized trials. The 42 trials were reported in 53 
references (Gillaizeau et al., 2013). There was a decision to include 2 other computer-
assisted dosage programs as subgroup analyses (Gillaizeau et al., 2013). The 40 
randomized trials where individuals who were chosen at random to receive therapy 
through a computer-based protocol and 2 were non-randomized controlled trials where 
the participant were chosen before the intervention was carried out. The reviewers 
excluded 143 of 199 full text articles because inclusion criteria were not met. The 
systematic review did not only specifically focus on computer-based systems for glucose 
management, this review also included: aminoglycoside antibiotics, oral anticoagulants, 
insulin, anesthetic agents, anti-rejection drugs, and antidepressants (Gillaizeau et al., 
2013). The studies utilized well-grounded outcomes measures such as: proportion of 
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participants with clinical amelioration, time for attaining a therapeutic effect, quantity of 
participants that experienced an unfavorable effect from the drug therapy, length of 
hospital stays, and the total direct and indirect cost per participant (Gillaizeau et al., 
2013). The insulin studies are as follows: Eight (80%) strictly evaluated patients admitted 
into the intensive care unit with hyperglycemia, six of the studies included those 
undergoing cardiac surgery, and two were patients in the critical care setting that were 
critically ill. Only one study included a patient with type 2 diabetes mellitus. A computer 
decision support system was integrated into healthcare systems EHR systems. Model 
Predictive Control (MPC) was the software that was integrated. This software 
incorporated an algorithm that aided in glucose management (Gillaizeau et al., 2013). 
This software generates time for the next glucose intervention with set intervals of 0.5 to 
4 hours (Gillaizeau et al., 2013). The six studies were a part of a closed loop insulin 
infusion for critically ill patients. This system was integrated by the European which 
wants to obtain a tighter glucose control for intensive care unit patients (Gillaizeau et al., 
2013). Three other studies utilized another software called Karlsburg Diabetes 
Management System (KADIS), EndoTool Glucose Management System, GIN Computer 
Software, and one other study utilized a weight-based insulin dose calculator (Gillaizeau 
et al., 2013).  
  In the ten insulin studies, the effects differed between studies and the statistical 
heterogeneity which determines a problem when conducting a meta- analysis was 
elevated at 83% (Gillaizeau et al., 2013). However, all studies were in favor of 
computerized assistance (Gillaizeau et al., 2013). In three of the studies there was no 
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significant difference noted. The group showed favor of a computerized glucose 
management system by SMD of 1.27, 95% to 1.98 (Gillaizeau et al., 2013). However, 
there were noted inconsistencies because one study exhibited after a patient underwent 
cardiac surgery and nine studies reported that the mean glucose level displayed a high 
heterogeneity.  
In the studies, a computer-based software was integrated into: healthcare 
organizations electronic health record (EHR), laptop computers, smartphones, table 
computers, or online calculators (Gillaizeau et al., 2013). In relation to insulin therapy 
specifically, evidence did not exhibit any variance between mortality or any other clinical 
unfavorable events. However, it was concluded by the researchers that computerized 
advice for drug dosage can benefit people taking insulin compared to dosing where the 
physician sets based on observation rather than computer assistance.  
Nieuwlaat et al. (2011). Nieuwlaat et al. (2011), evidence level I quality level A 
randomized control trial with meta-analysis, described different medications, the 
therapeutic ranges associated with them, and the monitoring that is required for them. 
The study examined how computerized clinical decision support systems (CCDSSs) have 
the potential to ameliorate efficacy and safety of medication administration. A systematic 
review was conducted and articles were retrieved from several different databases. These 
databases include: MEDLINE, EMBASE, and Evidence-Based Medicine Reviews 
(Nieuwlaat et al., 2011). There were 33 randomized controlled trials which assessed more 
than glycemic control. It assessed computerized clinical decision support systems 
(CCDSS) regarding: management vitamin K antagonists (14), insulin (6), 
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theophylline/aminophylline (4), aminoglycosides (3), digoxin (2), lidocaine (1), or as part 
of a multifaceted approach (3) (Nieuwlaat et al., 2011). The research question for this 
systematic review was: do CCDSSs improve process of care or patient outcomes for 
therapeutic drug monitoring and dosing (TDMD)? (Nieuwlaat et al., 2011). The study 
selection included RCTs and the aim was to assess the effect of a CCDSS on care 
measures, patient outcomes, the providing of dosing recommendations based on 
individualized patient data placed into an integrated CCDSS (Nieuwlaat et al., 2011). 
Data extracted consisted of a pair of reviewers that even attempted to contact the primary 
authors of the studies via email to validate accuracy and to aid in filling the gap for 
missing data (Nieuwlaat et al., 2011). There was a total of 25 out of 33 replies via email 
back to the reviewers totaling 76% (Nieuwlaat et al., 2011).  
The assessment of quality of all the RCTs for this study were scored for 
methodological quality on a 10-point scale with 0 being the lowest quality level and 10 
being the highest (Nieuwlaat et al., 2011). This scale was called the Jadad scale. The 
CCDSS was considered effective with a (p<0.05) which mean they were of statistically 
significance (Nieuwlaat et al., 2011). The database search rendered: n=14,794 that 
screened potentially eligible, there was a total of n=14,188 eligible to be screened after 
duplicates were removed, n=13,859 were excluded, n=329 articles were evaluated and 
excluded because they were not full-text, n=163 articles with 74 being NCTs and 50 did 
not evaluate CCDSS, 14 were only supplemental reports, 9 were deemed to have severe 
methodological flaws, 7 did not meet the definition of a CCDSS, 4  
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did not report outcomes that the author viewed as interesting, 4 had only the abstracts that 
were published, 1 included a previous review studies, n=166 studies that were included in 
the review met the TDMD criteria, n=33 (Nieuwlaat et al., 2011). In order for the CCDSS 
to be deemed effective, patient outcomes much improve > 50% (Nieuwlaat et al., 2011). 
As for data analysis and synthesis, CCDSS effectiveness was analyzed and a meta-
analysis was performed in comparison of at least 2 studies to compare (Nieuwlaat et al., 
2011). The risk ratios were analyzed with a Review Manager. The possibility of bias was 
assessed with a mismatch of clinicians and patients and was compared with the utilization 
of a chi-square test (Nieuwlaat et al., 2011). The chi-square test did not find any 
difference in process of care or patient outcomes (Pearson X2 evaluated the likelihood of 
the difference in outcomes which equaled 1.12, 2p=0.29 or patient outcomes PX2=1.35, 
2p=0.53 (Nieuwlaat et al., 2011). Likewise, the review exhibited that 18 out of the 30 
studies did reveal improvement in the process of care and 4 of 19 (21%) displayed 
improvement in patient outcomes (Nieuwlaat et al., 2011). Likewise, “all evaluable 
studies assessing insulin dosing for glycemic control exhibited an improvement” 
(Nieuwlaat et al., 2011, p. 13). It was concluded that decision makers at healthcare 
organizations should contemplate and assess the possibility of a CCDSS. CCDSSs have 
displayed how patient outcomes and the burden of cost can improve when it is 
implemented.  
Discussion of Findings in the Context of Framework 
The Chronic Care Model (2017), was utilized as the theoretical framework for 
this project. This model utilizes: the community, resources and policies, self-
38 
 
management, delivery system designs, health systems, organization of health care, 
decision support, and clinical information systems (Improving Chronic Illness Care 
Group Health Research, 2017). Each article addressed how resources and policies would 
need to be changed in order to implement a computer-based glucose management system. 
The articles explained how the delivery system design would have to be altered in order 
improves outcomes. This could be done by steering from the traditional paper protocol to 
a computer-based glucose management system. Each article discussed how computer-
based glucose management software would integrate into the EHR, meaning clinical 
information systems will be affected. Lastly, the model employs that self-management 
support is imperative. This is accomplished through education and training. Please see 
Appendix F for visual representation of the study findings and support and/or non-
support of the utilization of CBGMS.  
Recommendations 
As healthcare organizations continue to advance in technology, it is critical for 
leadership to take the initiative to research best practices and present it to upper 
leadership (administration). This would aid in advocating for advancement within their 
organizations information health systems. Furthermore, informatics leaders need to 
conduct research. In doing so, these disciplines could aid in providing that support to 
back the adoption of a computer-based glucose management system. Likewise, more 
research needed to be conducted and published to exhibit the benefits of a computer-
based glucose management system versus the traditional paper protocol. Also, 
organizations need to develop a performance reporting system so that data can easily be 
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extracted to measure performance and outcomes of inpatient diabetics. Additionally, 
further research that demonstrates the cost implications for computer-based glucose 
management systems in the inpatient setting is imperative. Lastly, this systematic review 
illustrates the potential need for healthcare organizations to have an evidence-based 
committee that are consistently researching and looking for ways to improve current 
processes and provide care based on evidence of best practices.  
Project Strengths and Limitations 
Strengths 
 One of the major strengths of the systematic review is being able to 
present the review to the DSC and the IDC at the practicum site. Being able to provide 
the knowledge and research to support computer-based glucose management systems is a 
plus for the practicum site. The practicum site sister facility already has this tool and 
being able to present this systematic review will aid the site in presenting this information 
to the appropriate party to push it forward.  
Limitations 
 The main limitations of the systematic review were the lack of available 
research sources available. There was not enough evidence to accurately come up with a 
definite conclusion as to the evidence-based benefits of a computerized management 
system. However, the evidence discovered did support the initiative to, at the minimum, 
consider adopting a computer-based glucose management system in the inpatient care 
setting. One must also consider the potential for bias and all the studies had to be 
interpreted with great caution.  
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Section 5: Dissemination Plan 
Analysis of Self 
Kavanoz and Yuksel (2016) identified the following skills one must possess to 
become a scholar: 
• effective writing and oral communication skills to present one’s research, 
• the ability to think critically and outside the box, 
• the ability to argue one’s point when conducting research, 
• the ability to critically appraise and interpret literature and extract data, 
and 
• skills to integrate and synthesize research. 
Conducting this systematic review provided me with the opportunity to use all the skills 
outlined by Kavanoz and Yuksel. I did so by identifying the research question, defining 
the inclusion and exclusion criteria, searching for different studies on CBGMS, 
deciphering and choosing studies based on the inclusion criteria, extracting data, and 
evaluating the studies for bias. Dissemination of the systematic review will entail 
presentation of the review to my practicum site’s DSC and the IDC. While working with 
the IDC and serving as a member of the organization’s DSC, I discussed the possibility of 
presenting the systematic review to these parties and gained feedback that this would be 
more useful. Making the end-product of my project work a review would allow for my 
findings and conclusions to be shared among key organizational stakeholders in their 
entirety. Dissemination at the practicum organization is tentatively set for November 9, 
2017, pending approval by my committee chair, co-chair, and URR member. My goal for 
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the future is for this systematic review to be shared with the organization’s other 
facilities.  
As I reflect on all my courses and practicum experiences, I realize I have grown 
significantly in relation to research. My courses and practicum experiences have given 
me the ability to understand the concept of researching a topic or issue. For example, in 
my current role as supervisor of day surgery and pre-assessment departments at my 
organization, I confront many different issues. For example, when it comes to changing 
current processes, I first go to the literature to see if there is evidence to support that 
change.  
Furthermore, my professional growth has enhanced tremendously in relation to 
my leadership style and communication competence and capability. For example, I have 
noticed that I do not possess just one type pf leadership style. My courses and practicum 
experiences have enabled me to distinguish the type of leader I truly am. I now know that 
my leadership style changes due to different circumstances or situations. For example, 
there are times when I should be autocratic (e.g., when staffing or meeting the needs of 
the unit), participative and/or democratic (e.g., in situations of shared governance, where 
I always try to obtain input from the staff regardless of whether I am the final decision 
maker or not), and transformational (e.g., by constantly communicating).  
I decided to pursue my DNP degree for several reasons. One reason was to grow 
as a leader. Without a doubt, my courses and practicum experiences have provided me 
with opportunities to develop leadership skills. My practicum setting is one that is very 
welcoming. My preceptor as well as the IDC I work with are also very welcoming and 
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make me feel a part of their team. The DNP program at Walden University has also 
taught me how to be a well-rounded scholarly nurse leader. I have adopted traits that I 
admire from my preceptor and practicum site, and I have received recognition from my 
own organization for doing so. I have been awarded the opportunity to be a part of 
several committees at my practicum site. Some of these committees are the Ethics 
Committee, Professional Development Committee, Performance Improvement 
Committee, and the Diabetes Steering Committee. Being a part of these committees has 
enabled me to be a welcoming voice and given me the opportunity to use the knowledge 
and skills I have gained from my DNP courses, coursework, and project work.  
Moreover, I have become competent in many areas. Some of the competencies I 
have developed to aid in successful evidence-based project implementation, evaluation, 
and dissemination are enhanced interpersonal skills, conflict resolution, time 
management skills, organizational skills, enhanced cognitive skills, and critical thinking 
skills. Likewise, my courses and practicum experience have given me the opportunity to 
work on several different projects alongside my preceptor and the IDC. Working with the 
IDC is very important to me, because my DNP project was centered on diabetes and 
diabetes management. Working on many different projects at my practicum setting has 
aided me in learning the different processes involved in disseminating information to the 
staff; the role that education, quality, and executive leadership play in making 






Throughout the remainder of my professional career, I plan to continue to 
collaborate with other leaders of the interdisciplinary team. As a leader, I will continue to 
be engaged in many different committees in order to make changes in my organization as 
well as in my community. I will continue to be exposed to different processes and 
implementations at my current organization. Likewise, I will also collaborate with other 
leaders at different organizations to gain knowledge on what works best for them and 
what has not worked. For example, in working with the DMP throughout my practicum 
experience, I found that there were constant changes being made to optimize the DMP; I 
continuously worked to address these changes with my preceptor and the IDC. In 
conclusion, I will also continue to be a part of the Performance Improvement Committee 
within my own organization to aid in disseminating information when changes occur 
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MODEL AND TOOLS 
Thank you for submitting the requested information. You now have permission to use the JHN 
EBP model and tools. 
Click here to download the tools. Reminder: You may not modify the model or the tools.  All 
reference to source forms should include “©The Johns Hopkins Hospital/The Johns Hopkins 
University.” 
We offer an excellent online course about our model/tools.  It is an engaging online experience, 
containing interactive elements, self-checks, instructional videos, and demonstrations of how to 
put EBP into use.  The course follows the EBP process from beginning to end and provides 
guidance to the learner on how to proceed, using the tools that are part of the Johns Hopkins 
Nursing EBP model. Take a sneak peek of the course. 
Click here for more information about our online course. Group rates available, 
email ijhn@jhmi.edu to inquire. 
Do you prefer hands-on learning?  We are offering a 5-day intensive Boot Camp where you will 
learn and master the entire EBP process from beginning to end.  Take advantage of our retreat-
type setting to focus on your project, collaborate with peers, and get the expertise and assistance 
from our faculty. Click here to learn more about EBP Boot Camp. 









Appendix B: Johns Hopkins Nursing Evidence-Based Practice Project Management 
Guide 






Comment / Resources 
Required
Step 1:  Recruit interprofessional 
team
Step 2:  Develop and refine the 
EBP question
Step 3:  Define the scope of the 
EBP question and identify 
stakeholders
Step 4:  Determine responsibility 
for project leadership
Step 5:  Schedule team meetings
Step 6:  Conduct internal and 
external search for evidence
Step 7: Appraise the level and 
quality of each piece of evidence
Step 8:  Summarize the individual 
evidence
Step 9:  Synthesize overall 
strength and quality of evidence
Step 10:  Develop 
recommendations for change 
based on evidence synthesis
   Strong, compelling evidence, 
consistent results
   Good evidence, consistent 
results
   Good evidence, conflicting 
results
   Insufficient or absent evidence
Step 11:  Determine fit, feasibility, 
and appropriateness of 
recommendation(s) for translation 
path
Step 12:  Create action plan
Step 13: Secure support and 
resources to implement  action 
plan
Step 14:  Implement action plan
Step 15:  Evaluate outcomes
Step 16: Report outcomes to 
stakeholders
Step 17: Identify next steps
Step 18: Disseminate findings
© The Johns Hopkins Hospital/Johns Hopkins University.  May not be used or reprinted without permission.
EVIDENCE:
TRANSLATION:
Initial EBP Question: 
EBP Team Members:  
PRACTICE QUESTION:
 
      Adapted from John Hopkins Medicine Center for Evidence Based Practice. John  
      Hopkins Nursing Evidence-Based Practice Model. Retrieved April 27, 2017 from    
      http://www.hopkinsmedicine.org/evidence-based-   
      practice/_docs/appendix_a_proj_management_guide.pdf 
52 
 
Appendix C: Johns Hopkins Nursing Evidence-Based Practice Question Development 
Tool
      Adapted from John Hopkins Medicine Center for Evidence Based Practice. John 












Level I  
Experimental study, randomized controlled trial (RCT) 
Systematic review of RCTs, with or without meta-analysis  
A High quality: Consistent, generalizable results; sufficient sample size for the study 
design; adequate control; definitive conclusions; consistent recommendations based 
on comprehensive literature review that includes thorough reference to scientific 
evidence 
 
B Good quality: Reasonably consistent results; sufficient sample size for the study 
design; some control, fairly definitive conclusions; reasonably consistent 
recommendations based on fairly comprehensive literature review that includes 
some reference to scientific evidence 
 
C Low quality or major flaws: Little evidence with inconsistent results; insufficient 
sample size for the study design; conclusions cannot be drawn 
Level II  
Quasi-experimental study 
Systematic review of a combination of RCTs and quasi-
experimental, or quasi-experimental studies only, with or without 
meta-analysis 
 
Level III  
Non-experimental study 
Systematic review of a combination of RCTs, quasi-experimental 
and non-experimental studies, or non-experimental studies only, 
with or without meta-analysis 














            Adapted from John Hopkins Medicine Center for Evidence Based Practice. John Hopkins 












Quality Appraisal of Research Studies 
• Does the researcher identify what is known and not known about the problem and how the 
study will address any gaps in knowledge? 
• Was the purpose of the study clearly presented? 
• Was the literature review current (most sources within last 5 years or classic)? 
• Was sample size sufficient based on study design and rationale? 
• If there is a control group: 
o Were the characteristics and/or demographics similar in both the control and 
intervention groups? 
o If multiple settings were used, were the settings similar? 
o Were all groups equally treated except for the intervention group(s)? 
• Are data collection methods described clearly? 
• Were the instruments reliable (Cronbach's α [alpha] > 0.70)?  
• Was instrument validity discussed? 
• If surveys/questionnaires were used, was the response rate > 25%? 
• Were the results presented clearly? 
• If tables were presented, was the narrative consistent with the table content? 
• Were study limitations identified and addressed? 








































































Quality Appraisal of Systematic Review with or without Meta-Analysis or Meta-Synthesis 
• Was the purpose of the systematic review clearly stated? 
• Were reports comprehensive, with reproducible search strategy? 
o Key search terms stated 
o Multiple databases searched and identified 
o Inclusion and exclusion criteria stated 
• Was there a flow diagram showing the number of studies eliminated at each level of 
review? 
• Were details of included studies presented (design, sample, methods, results, outcomes, 
strengths and limitations)? 
• Were methods for appraising the strength of evidence (level and quality) described? 
• Were conclusions based on results? 
o Results were interpreted 
o Conclusions flowed logically from the interpretation and systematic review question 






































Quality Rating Based on quality appraisal 
 
A  High quality:  consistent, generalizable results; sufficient sample size for the study design; 
adequate control; definitive conclusions; consistent recommendations based on comprehensive 
literature review that includes thorough reference to scientific evidence 
B  Good quality: reasonably consistent results; sufficient sample size for the study design; some 
control, and fairly definitive conclusions; reasonably consistent recommendations based on fairly 
comprehensive literature review that includes some reference to scientific evidence 
C  Low quality or major flaws: little evidence with inconsistent results; insufficient sample size for 
the study design; conclusions cannot be drawn 
 
      Adapted from John Hopkins Medicine Center for Evidence Based Practice. John  
      Hopkins Nursing Evidence-Based Practice Model. Retrieved April 27, 2017 from     
      http://www.hopkinsmedicine.org/evidence-based      

















Appendix F: Johns Hopkins Nursing Evidence-Based Individual Evidence Summary 
Tool/Table 
EBP Question: what is the current evidence supporting the utilization of a 
computer-based glucose management system for inpatient diabetic adults in the 










Sample Size & 
Setting 
Study findings that help 




















were included.  
In a general 









The findings in this 
systematic review exhibit that 
clinical decision support 
(CDS) systems aids as an 
optimizing approach to 
ameliorate care and reduce 
cost in the inpatient care 
setting. Encouraged to 

















































at random to 
receive one of 










All types of study designs that 
met Effective Practice and 
Organization of Care Group 
(EPOC) inclusion criteria was 
utilized. These include: 
randomized controlled trials 
(RCTs), non-randomized 
controlled trials (NRCTs), 
controlled before-and-after 
(CBA), and interrupted time 
series (ITS) studies. The 
participants were healthcare 
professionals with 
responsibility for patient care. 
It was concluded by the 
researchers that 



























Sample Size & 
Setting 
Study findings that help 









dosage can benefit patients 
taking insulin compared to 
dosing where the physician 
sets based on observation 














N. L., & 
Haynes, R. 































An overall 60% of the studies 
exhibited improvement for 
process care and patient 
outcomes. Recommendations 
were delivered at the time of 
care. Recommended insulin 
dosing and glucose control in 
patients in the Intensive Care 
Unit (ICU) was achieved and 
ranged from a blood glucose 
level of (60-140). There was 






























(1), or as 















Adapted from John Hopkins Medicine Center for Evidence Based Practice. John 






Appendix G: Excluded Studies and Reason for Exclusion 
1. Albisser, A. M. (2009). Technophobia, prescription checking and the future of 
diabetes management. Diabetologia, 52(6), 1013-1018. doi:10.1007/500125-009-
1341-8  
a. Reason for exclusion: observational study and non-control group to support 
evidence presented.  
2. Blair, D., Zamora, L. Brumbelow, R., and Mercer, L. (2012). Glucose 
management “a must” computerized software systems help boost outcomes, 
reduce cost. Nursing Management, 43(12), 10-12. 
doi:10.1097/01.NUMA,0000423781.61161.91 
a. Reason for exclusion: non-randomized trial, no control group, non-systematic 
review, research ended in 2012 nothing current within the last 5 years.  
3. Cavalcanti, A. B., Silva, E., Pereira, A. J., Caldeira-Filho, M., Almeida, F. F., 
Westphal, G. A., Beims, R., Fernandes, C. C., Correa, T. D., Gouvea, M. R., & 
Eluf-Neto, J. (2009). A randomized control-trial comparing a computer-assisted 
insulin infusion protocol with a strict and a conventional protocol for glucose 
control in critically ill patients. Journal of Critical Care, 24(3), 371-378. doi: 
https://doi.org/10.1016/j.jcrc.2009.05.005 
a. Reason for exclusion: not a systematic review, was a RCT but only studied 
167 patients in the Medical Intensive Care Unit, non-meta-analysis.  
4. Crockett, S. E., Suarez-Cavelier, J., Accola, K. D., Hadas, L. A., Harnage, D. L., 
Garrett, P. R.,  Butler, K. A., & Mulla, Z. D. (2012). Risk of postoperative 
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hypoglycemia in cardiovascular surgical patients receiving computer-based versus 
paper-based insulin therapy. Endocrine Practice, 18(4), 529-537. doi: 
10.4158/EP11337.OR 
a. Reason for exclusion: observational study, non-systematic review, non-meta-
analysis, non-RCTs, data analyzed with use of SAS software version 9.2. 
Kaplan-Meier survival curves, Wilcoxon test, and Cox model were utilized to 
provide statistical analysis. All were good analytic tools but there was not an 
sufficient control group.  
5. Dortch, M. J., Mowery, N. T., Ozdas, A., Dossett, L. Cao, H., Collier, B., Holdes, 
G., Miller, R. A., & May, A. K. (2008). A computerized insulin infusion titration 
protocol improves glucose control with less hypoglycemia compared to a manual 
titration protocol in a trauma intensive care unit. Journal of Parenteral and 
Enteral Nutrition, 32(1), 18-27. doi:https://doi.org/10.1177/014860710803200118 
a. Reason for exclusion: a cohort study with 552 critically ill patients. 
6. Eslami, S., Abu-Hanna, A., DeJonge, E., & DeKeizer, N., F. (2009). Tighter 
glycemic control and computerized decision-support systems: a systematic 
review. Intensive Care Medicine, 35(9), 1505-1517. doi:10.1007/s00134-009-
1542-0  
a. Reason for exclusion: systematic review with only 3 RCTs, data extracted 
from papers from 1950-2008.  
7. Frits, G. W., Cleveringa, K. J., Gorter, M., Van Gijsel, J., & Guy-Rutten, E. H. M. 
(2013). Computerized decision support systems in primary care for type 2 
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diabetes patients only improve patients’ outcomes when combined with feedback 
on performance and case management: a systematic review. Diabetes Technology 
& Therapeutics, 15(2), 180-192. doi:https://doi.org/10.1089/dia.2012.0201  
a. Reason for exclusion: this paper was a systematic review with meta-analysis 
and RCTs, however this paper only discussed type 2 diabetes.  
8. Harrison, R. L., Stalker, S. L., Henderson, R., & Lyerla, F. (2013). Use of a 
clinical decision support system to improve hypoglycemia management. 
MEDSURG Nursing, 22(4), 250-263.  
a. Reason for exclusion: no control group, results were limited to one facility, 
non-randomized trial, not a systematic review.  
9. Huser, V., Rasmussen, L. V., Oberg, R., Starren, J. B. (2011). Implementation of 
workflow engine technology to deliver basic clinical decision support 
functionality. BMC Medical Research, 11(43), 1-19.  
a. Reason for exclusion: paper did discuss clinical decision support systems but 
there was no control-group to compare results. Non-systematic review, non- 
meta-analysis, diabetes management was not specifically discussed. Objective 
assessed utilizing clinical decision support systems, potential bias.  
10. Kansagara, D., Fu R, F. M., Wolf, F. L., & Helfand, M. (2011). Intensive insulin 
therapy in hospitalized patients: a systematic review. Annals of Internal Medicine, 
154(4), 268-282.  
a. Reason for exclusion: more related to insulin therapy and not tools to aid in 
improving outcomes, inclusion criteria differ significantly to reviewers 
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inclusion criteria: perioperative care, myocardial infarction, stroke or brain 
injury settings.  
11. Magee, M. C. (2012). Improving IV insulin administration in a community 
hospital. Journal of Visualized  Experiments, 64, e3705.  
a. Reason for exclusion: objective assessed utilizing clinical decision support 
systems non-systematic review, data limited by only one community hospital. 
12. Mann, E. A., Allen, D. A., Serio-Melvin, M. L., Wolf, S. E., & Salinas, J. (2012). 
Clinician satisfaction with computer decision support in the intensive care unit. 
Dimensions Critical Care Nursing, 31(1), 31-36. 
doi:10.1097/DCC.0b013e31823a5553 
a. Reason for exclusion: data was collected by a written questionnaire to all 
clinical staff. A 5-point Likert scale was utilized to measure clinical 
satisfaction. Non-systematic, non-meta-analysis, non-RCTs, descriptive 
analysis was conducted.  
13. Mann, E. A., Jones, J. A., Wolf, S. E., & Wade, C. E. (2011). Computer decision 
support software safely improves glycemic control in the burn intensive care unit: 
a randomized controlled clinical study. Journal of Burn Care & Research, 32(2), 
246-255. doi:10.1097/BCR.0b013e31820aaebf 
a. Reason for exclusion: a prospective, paired randomization crossover trail was 
utilized, non-systematic review, non-meta-analysis.  
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14. Mould, D. R., D’ Haens, G., & Upton, R. N. (2016). Clinical decision support 
tools: the evolution of a revolution. Clinical Pharmacology and Therapeutics, 
99(4), 405-418.  
a. Reason for exclusion: not a systematic review, non-randomized trial, objective 
assessed the utilization of several clinical support systems non-specific to just 
glucose management. 
15. Saager, L., Collins, G. L., Burnside, B., Tymke, W. H., Zhang, L., Jacobsohn, E., 
& Avidan, M. (2008). A randomized study in diabetic patients undergoing cardiac 
surgery comparing computer-guided glucose management with a standard sliding 
scale protocol. Journal of Cardiothoracic and Vascular Anesthesia, 22(3), 377-
382. doi:10.1053/j.jvca.2007.09.013 
a. Reason for exclusion: research is more than 9 years its 10 years old, a 
prospective randomized control trial, limited participants (n=40), non-
systematic review, only involved diabetic patients undergoing cardiac surgery, 
subject characteristics did not match inclusion criteria: male, female, BMI, 
hypertension, chronic heart failure, myocardial infarctions, chronic renal 
failure, ejection fraction, oral insulin, length of diabetes, hemoglobin A1C 
level, and pre-operative triglycerides.  
16. Wan, Q., Makeham, M., Zwar, N. A., & Petche, S. (2012). Qualitative evaluation 
of a diabetes electronic decision support tool: views of users. BMC Medical 




a. Reason for exclusion: not a systematic review, objective assessed the users 
support of electronic decision support tools, did not present direct patient 
results or outcomes, qualitative study but the study design included only 



















Appendix H: Risk of Bias EPOC Checklist  
Suggested risk of bias criteria for EPOC reviews 
 
 
Risk of bias for studies with a separate control group  
- Randomized trials  
- Non-randomized trials  
- Controlled before-after studies  
 
Nine standard criteria are suggested for all randomized trials, non-randomized trials and 
controlled before-after studies. Further information can be obtained from the Cochrane 
handbook section on risk of bias. 
 
Was the allocation sequence adequately generated? 
Score “Low risk” if a random component in the sequence generation process is described 
(e.g. Referring to a random number table). Score “High risk” when a nonrandom method 
is used (e.g. performed by date of admission). Non-randomized trials and controlled 
before-after studies should be scored “High risk”. Score “Unclear risk” if not specified in 
the paper. 
 
Was the allocation adequately concealed? 
Score “Low risk” if the unit of allocation was by institution, team or professional and 
allocation was performed on all units at the start of the study; or if the unit of allocation 
was by patient or episode of care and there was some form of centralized randomization 
scheme, an on-site computer system or sealed opaque envelopes were used. Controlled 
before-after studies should be scored “High risk”. Score “Unclear risk” if not specified in 
the paper. 
 
Were baseline outcome measurements similar?1,2 
Score “Low risk” if performance or patient outcomes were measured prior to the 
intervention, and no important differences were present across study groups. In 
randomized trials, score “Low risk” if imbalanced but appropriate adjusted analysis was 
performed (e.g. Analysis of covariance). Score “High risk” if important differences were 
                                                 
1 If some primary outcomes were imbalanced at baseline, assessed blindly or affected by 
missing data and others were not, each primary outcome can be scored separately. 
2 If “Unclear risk” or “High risk”, but there is sufficient data in the paper to do an 
adjusted analysis (e.g. Baseline adjustment analysis or Intention to treat analysis) the 




present and not adjusted for in analysis. If randomized trials have no baseline measure of 
outcome, score “Unclear risk”. 
 
Were baseline characteristics similar? 
Score “Low risk” if baseline characteristics of the study and control providers are 
reported and similar. Score “Unclear risk” if it is not clear in the paper (e.g. 
characteristics are mentioned in text but no data were presented). Score “High risk” if 
there is no report of characteristics in text or tables or if there are differences between 
control and intervention providers. Note that in some cases imbalance in patient 
characteristics may be due to recruitment bias whereby the provider was responsible for 
recruiting patients into the trial. 
 
Were incomplete outcome data adequately addressed?1 
Score “Low risk” if missing outcome measures were unlikely to bias the results (e.g. the 
proportion of missing data was similar in the intervention and control groups or the 
proportion of missing data was less than the effect size i.e. unlikely to overturn the study 
result). Score “High risk” if missing outcome data was likely to bias the results. Score 
“Unclear risk” if not specified in the paper (Do not assume 100% follow up unless stated 
explicitly). 
 
Was knowledge of the allocated interventions adequately prevented during the 
study? 1 
Score “Low risk” if the authors state explicitly that the primary outcome variables were 
assessed blindly, or the outcomes are objective, e.g. length of hospital stay. Primary 
outcomes are those variables that correspond to the primary hypothesis or question as 
defined by the authors. Score “High risk” if the outcomes were not assessed blindly. 
Score “Unclear risk” if not specified in the paper. 
 
Was the study adequately protected against contamination? 
Score “Low risk” if allocation was by community, institution or practice and it is unlikely 
that the control group received the intervention. Score “High risk” if it is likely that the 
control group received the intervention (e.g. if patients rather than professionals were 
randomized). Score “Unclear risk” if professionals were allocated within a clinic or 
practice and it is possible that communication between intervention and control 
professionals could have occurred (e.g. physicians within practices were allocated to 
intervention or control) 
 
Was the study free from selective outcome reporting? 
Score “Low risk” if there is no evidence that outcomes were selectively reported (e.g. all 
relevant outcomes in the methods section are reported in the results section). Score “High 
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risk” if some important outcomes are subsequently omitted from the results. Score 
“Unclear risk” if not specified in the paper. 
 
Was the study free from other risks of bias? 
Score “Low risk” if there is no evidence of other risk of biases 
 
Risk of bias for interrupted time series studies 
 
Seven standard criteria are used for all interrupted time series studies. Further 
information can be obtained from the Cochrane handbook section on Risk of Bias and 
from the draft methods paper on risk of bias under the EPOC specific resources section of 
the EPOC website. 
 
Note: If the interrupted time series study has ignored secular (trend) changes and 
performed a simple t-test of the pre-versus post intervention periods without further 
justification, the study should not be included in the review unless reanalysis is possible. 
 
Was the intervention independent of other changes?  
Score “Low risk” if there are compelling arguments that the intervention occurred 
independently of other changes over time and the outcome was not influenced by other 
confounding variables/historic events during study period. If Events/variables identified, 
note what they are. Score “High risk” if reported that intervention was not independent of 
other changes in time. 
 
Was the shape of the intervention effect pre-specified? 
Score “Low risk” if point of analysis is the point of intervention OR a rational 
explanation for the shape of intervention effect was given by the author(s). Where 
appropriate, this should include an explanation if the point of analysis is NOT the point of 
intervention. Score “High risk” if it is clear that the condition above is not met. 
 
Was the intervention unlikely to affect data collection? 
Score “Low risk” if reported that intervention itself was unlikely to affect data collection 
(for example, sources and methods of data collection were the same before and after the 
intervention); Score “High risk” if the intervention itself was likely to affect data 
collection (for example, any change in source or method of data collection reported). 
 
Was knowledge of the allocated interventions adequately prevented during the 
study?3 
                                                 
3 If some primary outcomes were assessed blindly or affected by missing data and others 




Score “Low risk” if the authors state explicitly that the primary outcome variables were 
assessed blindly, or the outcomes are objective, e.g. length of hospital stay. Primary 
outcomes are those variables that correspond to the primary hypothesis or question as 
defined by the authors. Score “High risk” if the outcomes were not assessed blindly. 
Score “Unclear risk” if not specified in the paper. 
 
Were incomplete outcome data adequately addressed?3 
Score “Low risk” if missing outcome measures were unlikely to bias the results (e.g. the 
proportion of missing data was similar in the pre- and post-intervention periods or the 
proportion of missing data was less than the effect size i.e. unlikely to overturn the study 
result). Score “High risk” if missing outcome data was likely to bias the results. Score 
“Unclear risk” if not specified in the paper (Do not assume 100% follow up unless stated 
explicitly). 
 
Was the study free from selective outcome reporting? 
Score “Low risk” if there is no evidence that outcomes were selectively reported (e.g. all 
relevant outcomes in the methods section are reported in the results section). Score “High 
risk” if some important outcomes are subsequently omitted from the results. Score 
“Unclear risk” if not specified in the paper. 
 
Was the study free from other risks of bias? 
Score “Low risk” if there is no evidence of other risk of biases. 
e.g. should consider if seasonality is an issue (i.e. if January to June comprises the pre-
intervention period and July to December the post, could the “seasons’ have caused a 
spurious effect).  
 
Adapted from: Cochrane Effective Practice and Organization of Care (EPOC). Suggested 
risk of bias criteria for EPOC reviews. EPOC Resources for review authors, 2017. 
Available at: http://epoc.cochrane.org/epoc-specific-resources-review-authors. 
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Appendix I1: Figures 
 
 
Figure I1: Chronic care model.  Adapted from Improving Chronic Illness Care Group 


























            Figure I2: Adapted from John Hopkins Medicine Center for Evidence Based 
 Practice. John Hopkins Nursing Evidence-Based Practice Model. Retrieved April 





































Strength of overall 

























































Papers excluded after evaluation 
 (n=355) 
Potentially relevant 
papers identified by 
literature search 
(n=177) 
Papers retrieved for 
detailed examination  
(n=19) 
 





Trials with Meta Analysis 
(n=3) 
 
Papers excluded after evaluation of 
abstracts 
 (n=158) 
Papers excluded after full review 
of paper 
 (n=16) 
